News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Sanofi-Aventis (France)'s Acomplia Wins Approval from UK
March 26, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
PARIS (Reuters) - French drugmaker Sanofi-Aventis said on Wednesday that its troubled obesity-fighting product Acomplia had won approval from the National Institute for Health and Clinical Excellence (NICE).
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
Sanofi
MORE ON THIS TOPIC
Approvals
Rhythm Bounces Back from Phase 3 Fail with FDA Nod for Rare Obesity Injection
March 20, 2026
·
2 min read
·
Tristan Manalac
Approvals
Novo’s High Dose Wegovy Scores FDA Priority Voucher Program’s 4th Nod
March 19, 2026
·
2 min read
·
Heather McKenzie
FDA
Sarepta Plans FDA Run for Duchenne Exon Skippers Despite Confirmatory Trial Failure
March 19, 2026
·
2 min read
·
Annalee Armstrong
Policy
FDA Policy Tracker 2026: RMAT Awards for Assets on Hold, Animal Testing Alternatives
March 19, 2026
·
9 min read
·
BioSpace Editorial Staff
